Foundation Fighting Blindness
Foundation Fighting Blindness
Add to My Podcasts
Episodes
About
Reviews
Promote
News | AGTC Continues to Report Encouraging Data from its Phase 1/2 XLRP Gene Therapy Clinical Trial
3 minutes
Posted May 10, 2021 at 8:04 pm.
0:00
3:22
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
The company is planning the launch of a Phase 2/3 trial for its XLRP gene therapy
Previous
News | Microperimetry Emerging as a Valuable Tool in Measuring Treatment Efficacy in Clinical Trials
Next
Eye on the Cure Podcast | Episode 1: Welcome
← See all 275 episodes of Foundation Fighting Blindness
